Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
Tags:
Products Clinical

Naproxen 250mg among first 11 price concessions agreed for June

  • News

The Department of Health and Social Care and the National Assembly for Wales have agreed concessionary prices for the following 11 items for June 2019 prescriptions.

Drug
Strength
Form
Price
Amiloride
5mg
tablets (28)
£9.49
Betahistine
8mg
tablets (84)
£2.34
Betahistine
16mg
tablets (84)
£3.20
Celecoxib
100mg
capsules (60)
£3.29
Citalopram
40mg/ml
sugar-free oral drops (15)
£9.38
Ibandronic acid
50mg
tablets (28)
£55.00
Losartan
12.5mg
tablets (28)
£3.92
Naproxen
250mg
tablets (28)
£3.76
Naproxen
250mg
gastro-resistant tablets (56)
£9.95
Nortriptyline
10mg
tablets (100)
£4.98
Risedronate sodium
35mg
tablets (4)
£11.95
Table

View full table

Do these prices reflect the ones you have paid in June so far?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Tags:
Products Clinical
Latest News & Analysis

GPhC to 'assess' pharmacy technician minimum training levels

£5m retained margin uplift ‘approved’ in Northern Ireland

Revealed: London pharmacies will offer children’s MMR jabs following case surge

Will expanding access to naloxone OTC be the right move?

See All
UsernamePublicRestriction

Register

CD005942

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By